I don't think it has bottomed yetGive it time. If approval for manufacturig check points is NOT granted then ther bottom is a long way down.
The check points are for quality control of drug manufacturing. I'm now thinking that the explanation, one more check point was the "light" or PR description of the problem. I think they have a quality control problem. I suspect now that their blood plasma filtration process does not work very well, otherwise by now it would have been adopted by other blood fractionators.